Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SWOAR Trial: Swallowing Sparing IMRT vs Standard IMRT in Head and Neck Squamous Cell Carcinomas
NCT05187091Phase 3Recruiting
- Sponsor
- AIIMS New Delhi
- Start
- Jul 2021
- Primary completion
- Aug 2026
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial (2 arms), sponsored by AIIMS New Delhi. Primary endpoint: MD Anderson Dysphagia Inventory at 6 months. Started Jul 2021; status: recruiting.
Beyond the preview
Go deeper on NCT05187091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05187091.